Verification of Alternative Do-it-yourself Equipment Respirators for the COVID-19 Personal Protective Equipment (PPE)

NCT ID: NCT04375774

Last Updated: 2020-05-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

10 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-05-31

Study Completion Date

2020-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The COVID-19 pandemic health crisis forces health institutions to lower their standards of protection as supplies of personal protective equipment decrease despite the safety of front-line workers worldwide . This shortage specifically affects high-quality protective masks, such as those called FFP2. As alternatives, we offer a reusable mask based on a ventilation mask combined with a breathing filter for anesthesia breathing circuits. The purpose of the study is to assess the sealing potential of this mask in the field and possibly prove a non-inferior sealing compared to standard masks type FFP2.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The ongoing 2020 COVID-19 pandemic challenges healthcare providers (HCP) worldwide with a rapid consumption and shortage of personal protection equipment (PPE), especially high-level filtration respirator masks. Respirators used by HCPs are mainly single use face filtering pieces with at least level P2 protection for single shift use following European EN 149 standards defining protection level against hazardous particles.

In response to the risk of shortage we propose a novel reusable do-it-yourself (DIY) respirator assembled with already widely available components in hospital stocks: a standard breathing filter plugged in an anaesthesia facial mask held in place with a hook ring strapped to a silicone head harness. As reports of a modified full-face snorkelling (MFS) mask used for non-invasive ventilation in infected patients emerged in Italy, we reckon that it could also be used as PPE with a modified valve and breathing filter.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

COVID

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Enrolment will be a onetime selection of 10 healthy volunteers
Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

FFP2

Group Type OTHER

FFP2

Intervention Type DEVICE

Face Fit test of the FFP2 with the PortaCount® PRO+ 8038 from TSI

Facial mask

Group Type OTHER

Facial mask

Intervention Type DEVICE

Face Fit test of a conventional respirator facial mask with the PortaCount® PRO+ 8038 from TSI

Modified full-face snorkeling

Group Type OTHER

MFS

Intervention Type DEVICE

Face fit test of a MFS with the PortaCount® PRO+ 8038 from TSI

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

FFP2

Face Fit test of the FFP2 with the PortaCount® PRO+ 8038 from TSI

Intervention Type DEVICE

Facial mask

Face Fit test of a conventional respirator facial mask with the PortaCount® PRO+ 8038 from TSI

Intervention Type DEVICE

MFS

Face fit test of a MFS with the PortaCount® PRO+ 8038 from TSI

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* adult volunteers working in a first line healthcare service with basic knowledge of donning PPE including respirators
* 5 females and 5 males

Exclusion Criteria

* smoking or unhealthy participants with respiratory affections to avoid breathing difficulties during testing
* any known allergy towards medical silicone or any other material of each component and ingredients used for disinfection of the test area and material between participants
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Guillaume Lemaire, MD

Role: PRINCIPAL_INVESTIGATOR

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cliniques Universitaires Saint-Luc

Brussels, , Belgium

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Belgium

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Guillaume Lemaire, MD

Role: CONTACT

+3227641870

Marco Pettinger, MD

Role: CONTACT

00352 661 90 20 39

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Guillaume Lemaire, MD

Role: primary

+322764-1870

Marco Pettinger, MD

Role: backup

00352 661 90 20 39

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2020/15AVR/226

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.